Affordable Access

Publisher Website

Differential effects of octreotide on motor responses to nicotine in rats

Authors
Journal
Pharmacology Biochemistry and Behavior
0091-3057
Publisher
Elsevier
Publication Date
Volume
43
Issue
4
Identifiers
DOI: 10.1016/0091-3057(92)90498-5
Keywords
  • Somatostatin Release
  • Convulsions
  • Prostration/Immobility Syndrome
  • Cysteamine
  • Nicotinic Receptors

Abstract

Abstract We tested the hypothesis that brain somatostatin levels modify two motor behaviors evoked by ICV infusions of nicotine. Unrestrained, awake rats were given fixed-concentration infusions of nicotine until the prostration/immobility (PI) syndrome and convulsions were produced. Infusion duration ranged from 0.9 to 1.2 min for the PI syndrome and 2.5 to 4.9 min for the convulsions. Octreotide, a stable somatostatin analog (4.5 μg, ICV), significantly raised the threshold for nicotine convulsions 1.0 and 5.5 h after pretreatment but not at 24 or 48 h. Cysteamine, a somatostatin releaser and depletor (0.35–0.75 mg/rat, ICV), also caused a dose-dependent increase in seizure threshold. Similarities in the responses to octreotide and cysteamine suggest that depression of nicotine convulsions by cysteamine may be mediated by release of endogenous somatostatin. Neither octreotide nor cysteamine altered the threshold for the PI syndrome. These results support the view that one motor behavior evoked by nicotine is subject to control by somatostatin whereas another is not.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

Differential effects of octreotide on motor respon...

on Pharmacology Biochemistry and... December 1992

Differential effects of nicotine but not cathinone...

on Pharmacology Biochemistry and... March 1993

Differential effects of nicotine but not cathinone...

on Pharmacology Biochemistry and... Jan 01, 1993
More articles like this..